Jan 28 2011
Syneron Medical, producer of ablative and non-ablative medical devices, has secured an approval from the United States Food and Drug Administration (FDA) to sell its new skin rejuvenation product called the Tända Light Emitting Diode (LED) system.
The product received FDA clearance for treating rhytides, wrinkles and fine lines in the periorbital area.
The Tända LED skin rejuvenation system is the new addition in the Tända product series from Pharos Life, a subsidiary of Syneron Medical, and produces house-utilize light therapy equipment for aesthetic processes.
The Tända LED system uses a patented ultra luminous LED array that offers concentrated light channels for a partial phototherapy impact. This feature enables the system to offer five fold more power than current Tanda products, decreasing the number of treatments needed to two treatments a week.
The Tända LED system uses the Tända series’ modular design and its healing head can be used with existing Tända Clear and the Tända Regenerate systems. Syneron Medical plans to market the Tända LED skin rejuvenation system in the Q2 of 2011.